These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36921104)

  • 21. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
    Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
    Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
    Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies.
    Kim YY; Lee S; Shin J; Son WJ; Roh YH; Hwang JA; Lee JE
    Eur Radiol; 2022 Oct; 32(10):6723-6729. PubMed ID: 35849177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
    Nadarevic T; Giljaca V; Colli A; Fraquelli M; Casazza G; Miletic D; Štimac D
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013362. PubMed ID: 34611889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
    Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
    J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
    Glechner A; Wagner G; Mitus JW; Teufer B; Klerings I; Böck N; Grillich L; Berzaczy D; Helbich TH; Gartlehner G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009632. PubMed ID: 36999589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
    Fasani P; Sangiovanni A; De Fazio C; Borzio M; Bruno S; Ronchi G; Del Ninno E; Colombo M
    Hepatology; 1999 Jun; 29(6):1704-7. PubMed ID: 10347111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
    Wade R; South E; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Hodgson R; Dias S; Simmonds M; Rowe I; Thornton P; Eastwood A
    Health Technol Assess; 2023 Dec; 27(29):1-172. PubMed ID: 38149643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study.
    Pocha C; Dieperink E; McMaken KA; Knott A; Thuras P; Ho SB
    Aliment Pharmacol Ther; 2013 Aug; 38(3):303-12. PubMed ID: 23750991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
    Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
    Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.
    Sohn W; Kang D; Kang M; Guallar E; Cho J; Paik YH
    Clin Mol Hepatol; 2022 Oct; 28(4):851-863. PubMed ID: 36263667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
    Kim HL; An J; Park JA; Park SH; Lim YS; Lee EK
    Hepatology; 2019 Apr; 69(4):1599-1613. PubMed ID: 30365164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
    Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
    Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
    Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS
    BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis.
    Nahon P; Najean M; Layese R; Zarca K; Segar LB; Cagnot C; Ganne-Carrié N; N'Kontchou G; Pol S; Chaffaut C; Carrat F; Ronot M; Audureau E; Durand-Zaleski I; ; ; ;
    JHEP Rep; 2022 Jan; 4(1):100390. PubMed ID: 34977518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for people with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH; Htet NH; Nikolova D
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013731. PubMed ID: 38837373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
    Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
    Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Chou R; Cuevas C; Fu R; Devine B; Wasson N; Ginsburg A; Zakher B; Pappas M; Graham E; Sullivan SD
    Ann Intern Med; 2015 May; 162(10):697-711. PubMed ID: 25984845
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.